$0.026

0.001 (3.70%)

Want access to our research and new buy ideas?

Take a free 15 day trial - no credit card required.

Start your free trial now

General Information

AtCor Medical Holdings Limited
ACG
http://www.atcormedical.com
Health Care Equipment
7
281

Current Price Data+

Current Price $0.026
Open $0.028
High $0.028
Low $0.026
Last Close $0.027
Volume 22628
Price Movement $0.00 ( 3.70% )
  • +Security prices are delayed by at least 20 minutes and are indicative only.

Company Overview

Business Description

AtCor Medical Holdings Limited (ACG) is an Australia-based company that is a developer and marketer of the SphygmoCor system which measures central blood pressures and arterial stiffness non-invasively.

Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2017 A -4.4 -2.0 0.0% 0.0 0.0 0.0% 0.0%
2016 A -4.8 -2.4 0.0% 0.0 0.0 0.0% 0.0%
2015 A -1.4 -0.9 0.0% 0.0 0.0 0.0% 0.0%

Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2015 A 2016 A 2017 A 2015 A 2016 A 2017 A 2015 A 2016 A 2017 A
AtCor Medical (ACG) $8M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Cochlear (COH) $9,896M 0.1790 0.1128 0.1507 44.2020 39.7224 34.5188 1.57% 1.80% 2.03%
Fisher & Paykel Hlth (FPH) $6,665M 0.3370 0.0003 0.2073 38.6371 38.6243 31.9912 1.52% 1.81% 2.19%
Impedimed (IPD) $297M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
ResMed (RMD) $14,232M -0.2434 0.0000 0.0000 38.7984 0.0000 0.0000 1.74% 0.00% 0.00%

Financial Summary

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 4.56 0.00
Market 1.06 14.80 1.49 1.22
Sector 1.20 19.00 2.39 2.34

Directors

Name Position Start Date
Mr Duncan R Ross Chief Executive Officer, Managing Director 9 Nov 2006
Mr Donal Paul O'Dwyer Non-Executive Chairman 9 Nov 2005
Professor Michael Francis O'Rourke Non-Executive Director 6 Nov 2005
Mr David Lionel Brookes Non-Executive Director 4 Nov 2008
Mr Randall King Nelson Non-Executive Director 13 Nov 2015

Management

Name Position
Peter L Manley Chief Finance Officer,Company Secretary
Doug Kurschinski Senior Vice President and General Manager, AtCor Medical Inc
Mark Harding Vice President, Global Marketing & International Sales, AtCor Medical Pty Ltd

Substantial Shareholders

Holding Name
15,470,000 (7.61%) Cb Co Pty Ltd
15,205,572 (7.48%) National Nominees Limited
10,641,396 (5.24%) Pehila Pty Ltd (O'Rourke Superannuation Fund)

Calendar of Events

Date Event
30 August 2018 Report (Prelim)
23 February 2018 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.